FR531M - - Google Patents

Info

Publication number
FR531M
FR531M FR837316A FR837316A FR531M FR 531 M FR531 M FR 531M FR 837316 A FR837316 A FR 837316A FR 837316 A FR837316 A FR 837316A FR 531 M FR531 M FR 531M
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR837316A
Other languages
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR798293A external-priority patent/FR1333707A/fr
Application filed filed Critical
Priority to FR837316A priority Critical patent/FR531M/fr
Application granted granted Critical
Publication of FR531M publication Critical patent/FR531M/fr
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/32—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of salts of sulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR837316A 1958-07-10 1960-08-31 Active FR531M (xx)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR837316A FR531M (xx) 1958-07-10 1960-08-31

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB22148/58A GB851287A (en) 1958-07-10 1958-07-10 5-chlorotoluene-2:4-disulphonamide and alkali metal salts thereof
FR798293A FR1333707A (fr) 1959-06-23 1959-06-23 Procédé de fabrication du 5-chlorotoluène-2,4-disulfamide et de ses sels alcalins
FR837316A FR531M (xx) 1958-07-10 1960-08-31

Publications (1)

Publication Number Publication Date
FR531M true FR531M (xx) 1961-05-23

Family

ID=10174686

Family Applications (1)

Application Number Title Priority Date Filing Date
FR837316A Active FR531M (xx) 1958-07-10 1960-08-31

Country Status (2)

Country Link
FR (1) FR531M (xx)
GB (1) GB851287A (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB959229A (en) * 1960-11-18 1964-05-27 Kyowa Hakko Kogyo Company Ltd Method for producing l-isoleucine by fermentation process
EP0033042B1 (en) * 1980-01-28 1984-08-22 Merck & Co. Inc. Ophthalmic inserts for lowering intraocular pressure comprising carbonic anhydrase inhibitors
IE50901B1 (en) * 1980-03-04 1986-08-06 Merck & Co Inc Ophthalmic compositions of carbonic anhydrase inhibitors for topical application in the treatment of elevated intraocular pressure
KR100656716B1 (ko) 2000-11-21 2006-12-13 상꾜 가부시키가이샤 의약 조성물
AP2005003232A0 (en) 2002-08-19 2005-03-31 Pfizer Prod Inc Combination therapy for hyperproliferative diseases.
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
ES2382009T3 (es) 2006-12-01 2012-06-04 Bristol-Myers Squibb Company Derivados de N-((3-bencil)-2,2-(bis-fenil-)-propan-1-amina como inhibidores de CETP para el tratamiento de aterosclerosis y enfermedades cardiovasculares
CN105143203A (zh) 2013-04-17 2015-12-09 辉瑞大药厂 用于治疗心血管疾病的n-哌啶-3-基苯甲酰胺衍生物
ES2847904T3 (es) 2013-07-23 2021-08-04 Daiichi Sankyo Co Ltd Medicamento para la prevención o el tratamiento de la hipertensión
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
WO2020150473A2 (en) 2019-01-18 2020-07-23 Dogma Therapeutics, Inc. Pcsk9 inhibitors and methods of use thereof

Also Published As

Publication number Publication date
GB851287A (en) 1960-10-12

Similar Documents

Publication Publication Date Title
AT214638B (xx)
AT221043B (xx)
AT217439B (xx)
AT215747B (xx)
AT213316B (xx)
AT213446B (xx)
AT216227B (xx)
AT215751B (xx)
AT213908B (xx)
AT219815B (xx)
AT213337B (xx)
AT214270B (xx)
AT215738B (xx)
AT213670B (xx)
AT213631B (xx)
AT213558B (xx)
AT216612B (xx)
AT216749B (xx)
AT216771B (xx)
AT216803B (xx)
AT216831B (xx)
AT213557B (xx)
AT217982B (xx)
AT214348B (xx)
AT219868B (xx)